BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Grąt M, Stypułkowski J, Morawski M, Wronka KM, Wasilewicz M, Lewandowski Z, Grąt K, Wójcik Z, Patkowski W, Zieniewicz K. Shadows Behind Using Simple Risk Models in Selection of Hepatocellular Carcinoma Patients for Liver Transplantation. Ann Surg 2020;271:1124-31. [PMID: 30601254 DOI: 10.1097/SLA.0000000000003176] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Piñero F, Rubinstein F, Laurent A, Silva M, Cherqui D, Duvoux C. Comment on "Shadows Behind Using Simple Risk Models in Selection of Hepatocellular Carcinoma Patients for Liver Transplantation". Ann Surg 2021;274:e832-3. [PMID: 33214429 DOI: 10.1097/SLA.0000000000004511] [Reference Citation Analysis]
2 Grąt M, Zieniewicz K. Response to the Comment on "Shadows Behind Using Simple Risk Models in Selection of Hepatocellular Cancer Patients for Liver Transplantation". Ann Surg 2021;274:e833-6. [PMID: 33214427 DOI: 10.1097/SLA.0000000000004509] [Reference Citation Analysis]
3 Bhatti ABH, Qureshi AI, Tahir R, Dar FS, Khan NY, Zia HH, Riyaz S, Rana A. When to call it off: defining transplant candidacy limits in liver donor liver transplantation for hepatocellular carcinoma. BMC Cancer. 2020;20:754. [PMID: 32787864 DOI: 10.1186/s12885-020-07238-w] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
4 Rosenblatt RE, Halazun KJ. Striving for decreased post-transplant hepatocellular carcinoma recurrence without excluding potentially curable patients: the utility of tumor biology. Hepatobiliary Surg Nutr 2019;8:541-2. [PMID: 31673552 DOI: 10.21037/hbsn.2019.04.09] [Reference Citation Analysis]
5 Yang M, Tan W, Yang X, Zhuo J, Lin Z, Cen B, Lian Z, Li H, Lu D, Wei X, Zheng S, Xu X. Homocysteine: A novel prognostic biomarker in liver transplantation for alpha-fetoprotein- negative hepatocellular carcinoma. Cancer Biomark 2020;29:197-206. [PMID: 32623388 DOI: 10.3233/CBM-201545] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
6 Cao W, Chen Y, Han W, Yuan J, Xie W, Liu K, Qiu Y, Wang X, Li X. Potentiality of α-fetoprotein (AFP) and soluble intercellular adhesion molecule-1 (sICAM-1) in prognosis prediction and immunotherapy response for patients with hepatocellular carcinoma. Bioengineered 2021. [PMID: 34696675 DOI: 10.1080/21655979.2021.1990195] [Reference Citation Analysis]
7 Grąt M, Krasnodębski M, Krawczyk M, Stypułkowski J, Morawski M, Wasilewicz M, Lewandowski Z, Grąt K, Patkowski W, Zieniewicz K. Extremes of Liver Transplantation for Hepatocellular Carcinoma. J Clin Med 2019;8:E787. [PMID: 31163668 DOI: 10.3390/jcm8060787] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
8 Grąt K, Pacho R, Grąt M, Krawczyk M, Zieniewicz K, Rowiński O. Impact of Body Composition on the Risk of Hepatocellular Carcinoma Recurrence After Liver Transplantation. J Clin Med 2019;8:E1672. [PMID: 31614892 DOI: 10.3390/jcm8101672] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
9 Orci LA, Combescure C, Fink M, Oldani G, Compagnon P, Andres A, Berney T, Toso C. Predicting recurrence of hepatocellular carcinoma after liver transplantation using a novel model that incorporates tumor and donor-related factors. Transpl Int 2021. [PMID: 34784081 DOI: 10.1111/tri.14161] [Reference Citation Analysis]
10 Mahmud N, John B, Taddei TH, Goldberg DS. Pre-transplant alpha-fetoprotein is associated with post-transplant hepatocellular carcinoma recurrence mortality. Clin Transplant. 2019;33:e13634. [PMID: 31177570 DOI: 10.1111/ctr.13634] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
11 Lozanovski VJ, Ramouz A, Aminizadeh E, Al-Saegh SA, Khajeh E, Probst H, Picardi S, Rupp C, Chang DH, Probst P, Mehrabi A. Prognostic role of selection criteria for liver transplantation in patients with hepatocellular carcinoma: a network meta-analysis. BJS Open 2022;6:zrab130. [PMID: 35211739 DOI: 10.1093/bjsopen/zrab130] [Reference Citation Analysis]